Asia PDL1 study among NSCLC patients

Trial Identifier: D4191R00002
Sponsor: AstraZeneca
Collaborator:
Not Applicable
NCTID:: NCT03037086
Start Date: October 2015
Primary Completion Date: February 2017
Study Completion Date: February 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Guangdong Guangzhou, Guangdong, China
Japan, Fukuoka-Ken Iizuka-shi, Fukuoka-Ken, Japan
Japan, Fukushima-Ken Fukushima-shi, Fukushima-Ken, Japan
South Korea Seoul, South Korea